Midterm outcome after aortic root replacement with stentless porcine bioprostheses

Objective: Midterm clinical outcome was evaluated after aortic root replacement with Freestyle ® stentless aortic root bioprostheses. Methods: Between April 1996 and December 2007, 301 patients underwent aortic valve replacement with stentless Medtronic Freestyle ® bioprostheses in full-root techniq...

Full description

Bibliographic Details
Main Authors: Ennker, I., Albert, A., Dalladaku, F., Rosendahl, U., Ennker, J., Florath, Ines
Format: Journal Article
Published: 2011
Online Access:http://hdl.handle.net/20.500.11937/5902
_version_ 1848744925514956800
author Ennker, I.
Albert, A.
Dalladaku, F.
Rosendahl, U.
Ennker, J.
Florath, Ines
author_facet Ennker, I.
Albert, A.
Dalladaku, F.
Rosendahl, U.
Ennker, J.
Florath, Ines
author_sort Ennker, I.
building Curtin Institutional Repository
collection Online Access
description Objective: Midterm clinical outcome was evaluated after aortic root replacement with Freestyle ® stentless aortic root bioprostheses. Methods: Between April 1996 and December 2007, 301 patients underwent aortic valve replacement with stentless Medtronic Freestyle ® bioprostheses in full-root technique at a single center. Concomitant coronary artery bypass grafting (CABG) was required in 96 patients (32%). In 94 patients (31%), the ascending aorta was replaced. The mean age was 71.6±9.1 (range: 36-89) years. Follow-up was closed in October 2008, 99% complete and encompassed 916 patient-years. Results: Overall mortality within 30 days was 5%. A total of 62 patients died during the follow-up period. Overall survival at 5 and 9 years was 74±4% and 53±6%, respectively. Re-operations were required in three patients: in one patient due to structural valve deterioration, and in two patients due to prosthetic valve endocarditis. Non-structural dysfunctions were not observed. In eight patients, prosthetic valve endocarditis occurred, in most of them (N=6) during the first year after surgery. Rate of freedom from re-operation, structural valve deterioration, prosthetic valve endocarditis, thrombo-embolic and major bleeding events at 9 years was 94±6%, 94±6%, 94±3%, 87±5%, and 95±2%, respectively. The linearized rates of late adverse events in percent per patient-year were 0.35, 0.12, 0.83, 1.7, and 0.7, respectively, for re-operation, structural valve deterioration, prosthetic valve endocarditis, thrombo-embolic and major bleeding events. A little less than a quarter (22%) of the patients required anticoagulation therapy. Conclusions: Aortic root replacement with the stentless Freestyle ® bioprosthesis provided a respectable short-term mortality, optimal valve durability and acceptable rates of valve-related complications within 9 years.
first_indexed 2025-11-14T06:09:12Z
format Journal Article
id curtin-20.500.11937-5902
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:09:12Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-59022017-09-13T14:40:29Z Midterm outcome after aortic root replacement with stentless porcine bioprostheses Ennker, I. Albert, A. Dalladaku, F. Rosendahl, U. Ennker, J. Florath, Ines Objective: Midterm clinical outcome was evaluated after aortic root replacement with Freestyle ® stentless aortic root bioprostheses. Methods: Between April 1996 and December 2007, 301 patients underwent aortic valve replacement with stentless Medtronic Freestyle ® bioprostheses in full-root technique at a single center. Concomitant coronary artery bypass grafting (CABG) was required in 96 patients (32%). In 94 patients (31%), the ascending aorta was replaced. The mean age was 71.6±9.1 (range: 36-89) years. Follow-up was closed in October 2008, 99% complete and encompassed 916 patient-years. Results: Overall mortality within 30 days was 5%. A total of 62 patients died during the follow-up period. Overall survival at 5 and 9 years was 74±4% and 53±6%, respectively. Re-operations were required in three patients: in one patient due to structural valve deterioration, and in two patients due to prosthetic valve endocarditis. Non-structural dysfunctions were not observed. In eight patients, prosthetic valve endocarditis occurred, in most of them (N=6) during the first year after surgery. Rate of freedom from re-operation, structural valve deterioration, prosthetic valve endocarditis, thrombo-embolic and major bleeding events at 9 years was 94±6%, 94±6%, 94±3%, 87±5%, and 95±2%, respectively. The linearized rates of late adverse events in percent per patient-year were 0.35, 0.12, 0.83, 1.7, and 0.7, respectively, for re-operation, structural valve deterioration, prosthetic valve endocarditis, thrombo-embolic and major bleeding events. A little less than a quarter (22%) of the patients required anticoagulation therapy. Conclusions: Aortic root replacement with the stentless Freestyle ® bioprosthesis provided a respectable short-term mortality, optimal valve durability and acceptable rates of valve-related complications within 9 years. 2011 Journal Article http://hdl.handle.net/20.500.11937/5902 10.1016/j.ejcts.2010.12.010 unknown
spellingShingle Ennker, I.
Albert, A.
Dalladaku, F.
Rosendahl, U.
Ennker, J.
Florath, Ines
Midterm outcome after aortic root replacement with stentless porcine bioprostheses
title Midterm outcome after aortic root replacement with stentless porcine bioprostheses
title_full Midterm outcome after aortic root replacement with stentless porcine bioprostheses
title_fullStr Midterm outcome after aortic root replacement with stentless porcine bioprostheses
title_full_unstemmed Midterm outcome after aortic root replacement with stentless porcine bioprostheses
title_short Midterm outcome after aortic root replacement with stentless porcine bioprostheses
title_sort midterm outcome after aortic root replacement with stentless porcine bioprostheses
url http://hdl.handle.net/20.500.11937/5902